ask="2.00"
ask_size="2000"
average_daily_volume="549560"
bid="1.93"
bid_size="1100"
book_value="1.72"
change="-0.04"
change_from_200_day_moving_average="-0.73"
change_from_50_day_moving_average="-0.16"
change_from_52_week_high="-4.01"
change_From_52_week_low="1.68"
change_in_percent="-2.00%"
close="1.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.25"
ebitda="-3.16M"
eps_estimate_current_year="-1.75"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="7629000"
high="2.01"
high_52_weeks="5.97"
last_trade_date="3/1/2017"
last_trade_price="1.96"
last_trade_size="188"
last_trade_time="4:00pm"
low="1.95"
low_52_weeks="0.28"
market_capitalization="30.17M"
moving_average_200_day="2.69"
moving_average_50_day="2.12"
name="Eleven Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="12.00"
open="2.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-27.00%"
percent_change_from_50_day_moving_average="-7.46%"
percent_change_from_52_week_high="-67.17%"
percent_change_from_52_week_low="+592.58%"
previous_close="2.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.17"
price_per_sales="1.04"
revenue="29.72M"
shares_outstanding="15393000"
short_ratio="3.05"
stock_exchange="NGM"
symbol="EBIO"
volume="206024"
weeks_range_52="0.28 - 5.97"
